News

North American-based SOHM is a generic pharmaceutical manufacturer that produces and markets generic drugs, covering all major treatment categories. SOHM Corporate Strategy vice president Shailesh Shah said that

Bemis has posted a net income of $61.42m for the third quarter 2010, or $0.56 per diluted share, compared to $35.84m, or $0.33 per diluted share, for the

Prior to Ancora Pharma, Siber worked as the vice president and chief scientific officer of Wyeth. Prior to his work at Wyeth Vaccines Research, Siber was associate professor

Before joining Idenix in 2007, Renaud worked as the senior vice president and chief financial officer of Keryx Biopharmaceuticals. Idenix Pharma lead director of the board of directors

Sanofi-aventis has posted a net income of EUR1.66bn for the third quarter 2010, compared to EUR1.53bn for the comparable period in 2009. Operating income was EUR1.71bn, compared to

Amira Pharma Clinical Development vice president Isabelle DeArmond said that they are excited to begin their journey exploring the therapeutic value of AM152, a potentially novel anti-fibrotic agent.

Théramex offers a range of women’s health products sold in 50 countries worldwide. The company’s pipeline includes a new oral contraceptive based on natural estrogens, NOMAC/E2, which has

Prior to joining Stirling, Kean has held positions as a tutor at the University of Technology in Sydney and as a senior researcher in fields including the Financial